Idiopathic CD4+ lymphocytopenia: Natural history and prognostic factors

Blood

Volumn 112, Issue 2, 2008, Pages 287-294

  Zonios, Dimitrios I ^a,d   Falloon, Judith ^a   Bennett, John E ^a   Shaw, Pamela A ^a   Chaitt, Doreen ^a   Baseler, Michael W ^b   Adelsberger, Joseph W ^b   Metcalf, Julia A ^a   Polis, Michael A ^a   Kovacs, Stephen J ^a   Kovacs, Joseph A ^c   Davey, Richard T ^a   Lane, H Clifford ^a   Masur, Henry ^c   Sereti, Irini ^a,d  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b SAIC FREDERICK INC   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL KINETICS; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HUMAN; IDIOPATHIC DISEASE; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; FOLLOW UP; LYMPHOCYTE ACTIVATION; MICROBIOLOGY; MIDDLE AGED; MULTICENTER STUDY; PROSPECTIVE STUDY; SURVIVAL; T LYMPHOCYTE;

ADULT; AGED; AGED, 80 AND OVER; AUTOIMMUNE DISEASES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHOCYTE ACTIVATION; LYMPHOPENIA; MALE; MIDDLE AGED; OPPORTUNISTIC INFECTIONS; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; T-LYMPHOCYTES;

EID: 47649120740     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2007-12-127878     Document Type: Article

References (34)

1. Anonymous. Unexplained CD4+ T-lymphocyte depletion in persons without evident HIV infectionUnited States. MMWR Morb Mortal Wkly Rep. 1992; 41:541-545.
2. Duncan RA, von Reyn CF, Alliegro GM. Toossi Z, Sugar AM, Levitz SM. Idiopathic GD4+ T-lymphocytopenia: four patients with opportunistic infections and no evidence of HIV infection. N Engl J Med. 1993;328:393-398.
3. Ho DD, Cao Y, Zhu T, et al. Idiopathic CD4+ Tlymphocytopenia: immunodeficiency without evidence of HIV infection. N Engl JMed. 1993;328: 380-385.
4. Smith DK, Neal JJ, Holmberg SD. Unexplained opportunistic infections and CD4+ T-lymphocytopenia without HIV infection: an investigation of cases in the United States. The Centers for Disease Control Idiopathic CD4+ T-lymphocytopenia Task Force. N Engl J Med. 1993;328:373-379.
5. SpiraTJ, Jones BM, Nicholson JK, et al. Idiopathic CD4+ T-lymphocytopenia: an analysis of five patients with unexplained opportunistic infections. N Engl J Med. 1993;328:386-392.
6. Fauci AS. CD4+T-lymphocytopenia without HIV infection: no lights, no camera, just facts. N Engl J Med. 1993;328:429-431.
7. Sneller MC, Eisenstein EM, Baseler M, et al. A unique syndrome of immunodeficiency and autoimmunity associated with absent T cell CD2 expression. J Clin Immunol. 1994;14:359-367.
8. Zonios Dl, Falloon J, Huang CY, Chaitt D, Bennett JE. Cryptococcosis and idiopathic CD4 lymphocytopenia. Medicine (Baltimore). 2007;86:78-92.
9. Anthony KB, Yoder C, Metcalf JA, et al. Incomplete CD4T cell recovery in HIV-1 infection after 12 months of highly active antiretroviral therapy is associated with ongoing increased CD4 T cell activation and turnover. J Acquir Immune Defic Syndr. 2003;33:125-133.
10. Fry T J, Connick E, Falloon J, et al. A potential role for interleukin-7 in T-cell homeostasis. Blood. 2001;97:2983-2990.
11. Malaspina A, Moir S, Chaitt DG. et al. Idiopathic CD4+ T lymphocytopenia is associated with increases in immature/transitional B cells and serum levels of IL-7. Blood. 2007;109:2086-2088.
12. Psallidopoulos MC, Schnittman SM, Thompson LM 3rd, et al. Integrated proviral human immunodeficiency virus type 1 is present in CD4+ peripheral blood lymphocytes in healthy seropositive individuals. J Virol. 1989;63:4626-4631.
13. Guidelines for the performance of CD4+ T-cell determinations in persons with human immunodeficiency virus infection. MMWR Recomm Rep. 1992;41:1-17.
14. Boyum A. Separation of blood leucocytes, granulocytes and lymphocytes. Tissue Antigens. 1974; 4:269-274.
15. Lempicki RA, Kovacs JA. Baseler MW. et al. Impact of HIV-1 infection and highly active antiretroviral therapy on the kinetics of CD4+ and CD8+ Tcell turnover in HIV-infected patients. Proc Natl Acad Sci U S A. 2000;97:13778-13783.
16. Sereti I, Martinez-Wilson H, Metcalf JA, et al. Long-term effects of intermittent interleukin 2 therapy in patients with HIV infection: characterization of a novel subset of CD4(+)/CD25(+) Tcells. Blood. 2002;100:2159-2167.
17. Laird N, Ware J. Random-effects models for longitudinal data. Biometrics. 1982;38:963-974.
18. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep. 1992;41:1-19.
19. Verbeke G, Molenberg G. Linear Models for Longitudinal Data. Springer: New York; 2000.
20. Aledort LM, Operskalski EA, Dietrich SL, et al. Low CD4+ counts in a study of transfusion safety: the Transfusion Safety Study Group. N Engl J Med. 1993;328:441-442.
21. Busch MP, Valinsky JE, Paglieroni T, et al. Screening of blood donors for idiopathic CD4+ T-lymphocytopenia. Transfusion. 1994;34:192-197.
22. Walker UA, Warnatz K. Idiopathic CD4 lymphocytopenia. CurrOpin Rheumatol. 2006;18:389-395.
23. Sinicco A, MaielloA, Raiteri R, et al. Pneumocystis carinii in a patient with pulmonary sarcoidosis and idiopathic CD4+ T lymphocytopenia. Thorax. 1996;51:446-447; discussion 448-449.
24. Prekates A, Kyprianou T, Paniara O, Roussos C. Pneumocystis carinii pneumonia in a HIVseronegative patient with untreated rheumatoid arthritis and CD4+ T-lymphocytopenia. Eur Respir J. 1997;10:1184-1186.
25. King C, Ilic A, Koelsch K, Sarvetnick N. Homeostatic expansion of T cells during immune insufficiency generates autoimmunity. Cell. 2004;117: 265-277.
26. Allan SE. Crome SQ. Crellin NK, et al. Activationinduced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int Immunol. 2007;19:345-354.
27. Laurence J, Mitra D, SteinerM, Lynch DH, Siegal FP, Staiano-Coico L. Apoptotic depletion of CD4+ T cells in idiopathic GD4+ T lymphocytopenia. J Clin Invest. 1996;97:672-680.
28. Roger PM, Bernard-Pomier G, Counillon E, Breittmayer JP, Bernard A. Dellamonica P. Overexpression of Fas/CD95 and Fas-induced apoptosis in a patient with idiopathic CD4+ Tlymphocytopenia. Clin Infect Dis. 1999;28:1012-1016.
29. Salit RB. Hankey KG. Yi R, RapoportAP, Mann DL. Detection of CD4(+) T-cell antibodies in a patient with idiopathic CD4 T lymphocytopenia and cryptococcal meningitis. Br J Haematol. 2007;139:133-137.
30. Hazenberg MD, Hamann D, Schuitemaker H, Miedema F. T cell depletion in HIV-1 infection: how CD4+ T cells go out of stock. Nat Immunol. 2000;1:285-289.
31. Rosenberg SA. Sportes C, Ahmadzadeh M, et al. IL-7 administration to humans leads to expansion of CD8+ and CD4+ cells but a relative decrease of CD4+ T-regulatory cells. J Immunother. 2006; 29:313-319.
32. Warnatz K, Draeger R, Schlesier M., Peter HH. Successful IL-2 therapy for relapsing herpes zoster infection in a patient with idiopathic CD4+ T lymphocytopenia. Immunobiology. 2000;202: 204-211.
33. Cunningham-Rundles C, Murray HW, Smith JP. Treatment of idiopathic CD4 T lymphocytopenia with IL-2. Clin Exp Immunol. 1999;116:322-325.
34. Kovacs JA, Lempicki RA, Sidorov IA, et al. Induction of prolonged survival of CD4+ T lymphocytes by intermittent IL-2 therapy in HIV-infected patients. J Clin Invest. 2005;115:2139-2148.